Marksans Pharma Ltd MARKSANS
Trading Information
- Previous Close Price
- ₹314.18
- Day Range
- ₹303.00–314.95
- 52-Week Range
- ₹97.45–328.80
- Bid/Ask
- ₹304.68 / ₹305.56
- Market Cap
- ₹138.47 Bil
- Volume/Avg
- 1.7 Mil / 4.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 41.61
- Price/Sales
- 6.12
- Dividend Yield (Trailing)
- 0.20%
- Dividend Yield (Forward)
- 0.20%
- Total Yield
- 0.20%
Company Profile
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal, and oncologic drugs as well as antibiotics and antiallergic medications. Geographically, the majority of its revenue is generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, and the Rest of the World.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 815
- Website
- https://www.marksanspharma.com
Comparables
Valuation
|
Metric
|
MARKSANS
|
AUROPHARMA
|
532815
|
|---|---|---|---|
Price/Earnings (Normalized) | 41.61 | 24.76 | 52.55 |
Price/Book Value | 6.71 | 2.98 | 5.91 |
Price/Sales | 6.12 | 3.02 | 4.08 |
Price/Cash Flow | 39.40 | 23.01 | 36.20 |
Price/Earnings
MARKSANS
AUROPHARMA
532815
Financial Strength
|
Metric
|
MARKSANS
|
AUROPHARMA
|
532815
|
|---|---|---|---|
Quick Ratio | 2.99 | 0.96 | 0.86 |
Current Ratio | 4.78 | 1.98 | 1.61 |
Interest Coverage | 33.90 | 15.28 | 4.55 |
Quick Ratio
MARKSANS
AUROPHARMA
532815
Profitability
|
Metric
|
MARKSANS
|
AUROPHARMA
|
532815
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
MARKSANS
AUROPHARMA
532815
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Vtrfqpbc | Dwhg | $790.4 Bil | |||
| Johnson & Johnson
JNJ
| Vnjyrfrrf | Pwz | $388.5 Bil | |||
| AbbVie Inc
ABBV
| Djjdxcbv | Fgh | $344.1 Bil | |||
| Merck & Co Inc
MRK
| Xxbpxmry | Hjf | $288.2 Bil | |||
| Roche Holding AG ADR
RHHBY
| Fcfqjjkjqw | Ktnv | $258.7 Bil | |||
| AstraZeneca PLC ADR
AZN
| Bzxsrmmvjt | Gky | $242.3 Bil | |||
| Novartis AG ADR
NVS
| Fmddpcbg | Rphz | $234.2 Bil | |||
| Amgen Inc
AMGN
| Qtwfgwxc | Fsv | $173.4 Bil | |||
| Pfizer Inc
PFE
| Qgkwmrfb | Fmtjj | $164.8 Bil | |||
| Sanofi SA ADR
SNY
| Pfvkjlh | Fdt | $144.3 Bil |
United States